These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 2602657)
1. Metabolism and disposition of (R)-4-[3-(2-hydroxy-2-phenyl)ethylamino-3-methylbutyl]benzamide Hcl (LY 195448) in rodents. Ho DH; Covington WP; Lin J; Brown NS; Newman RA Res Commun Chem Pathol Pharmacol; 1989 Nov; 66(2):255-67. PubMed ID: 2602657 [TBL] [Abstract][Full Text] [Related]
2. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites. Prakash C; Cui D Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030 [TBL] [Abstract][Full Text] [Related]
3. Disposition and metabolism of prinomide in laboratory animals. Egger H; Itterly W; John V; Rodebaugh R; Shimanskas C; Stancato F; Kapoor A Drug Metab Dispos; 1988; 16(4):568-75. PubMed ID: 2903025 [TBL] [Abstract][Full Text] [Related]
4. Metabolism, distribution and excretion of a selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in rats and dogs. Prakash C; Cui D; Potchoiba MJ; Butler T Drug Metab Dispos; 2007 Aug; 35(8):1350-64. PubMed ID: 17496205 [TBL] [Abstract][Full Text] [Related]
5. Disposition and biotransformation of quinpirole, a new D-2 dopamine agonist antihypertensive agent, in mice, rats, dogs, and monkeys. Whitaker NG; Lindstrom TD Drug Metab Dispos; 1987; 15(1):107-13. PubMed ID: 2881745 [TBL] [Abstract][Full Text] [Related]
6. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126. Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109 [TBL] [Abstract][Full Text] [Related]
7. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS. Prakash C; Soliman V Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906 [TBL] [Abstract][Full Text] [Related]
8. Metabolism and disposition of diphacinone in rats and mice. Yu CC; Atallah YH; Whitacre DM Drug Metab Dispos; 1982; 10(6):645-8. PubMed ID: 6130915 [TBL] [Abstract][Full Text] [Related]
9. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs. Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830 [TBL] [Abstract][Full Text] [Related]
10. Lauramide diethanolamine absorption, metabolism, and disposition in rats and mice after oral, intravenous, and dermal administration. Mathews JM; deCosta K; Thomas BF Drug Metab Dispos; 1996 Jul; 24(7):702-10. PubMed ID: 8818565 [TBL] [Abstract][Full Text] [Related]
11. Metabolism and disposition of the dopaminergic agonist 5-hydroxy-6-methyl-2-di-n-propylaminotetralin in the rat. Koble DL; Koons JC; Fischer LJ Drug Metab Dispos; 1985; 13(3):305-11. PubMed ID: 2861988 [TBL] [Abstract][Full Text] [Related]
12. Disposition of [14C]velnacrine maleate in rats, dogs, and humans. Turcan RG; Hillbeck D; Hartley TE; Gilbert PJ; Coe RA; Troke JA; Vose CW Drug Metab Dispos; 1993; 21(6):1037-47. PubMed ID: 7905382 [TBL] [Abstract][Full Text] [Related]
13. Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys. Matsumoto S; Yoshida K; Itogawa A; Tagawa M; Fujii T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Oct; 43(10):1095-102. PubMed ID: 8267676 [TBL] [Abstract][Full Text] [Related]
14. Disposition of the novel antitumour agent xanthenone-4-acetic acid in the mouse: identification of metabolites and routes of elimination. Kestell P; Rewcastle GW; Baguley BC Xenobiotica; 1994 Jul; 24(7):635-47. PubMed ID: 7975728 [TBL] [Abstract][Full Text] [Related]
15. Disposition of remoxipride in different species. Species differences in metabolism. Widman M; Nilsson LB; Bryske B; Lundström J Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555 [TBL] [Abstract][Full Text] [Related]
16. Metabolism of 2,6-dichlorobenzamide in rats and mice. Bakke JE; Larsen GL; Feil VJ; Brittebo EB; Brandt I Xenobiotica; 1988 Jul; 18(7):817-29. PubMed ID: 3176520 [TBL] [Abstract][Full Text] [Related]
17. Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans. Denissen JF; Grabowski BA; Johnson MK; Buko AM; Kempf DJ; Thomas SB; Surber BW Drug Metab Dispos; 1997 Apr; 25(4):489-501. PubMed ID: 9107549 [TBL] [Abstract][Full Text] [Related]
18. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [TBL] [Abstract][Full Text] [Related]
19. Disposition in humans of racemic picenadol, an opioid analgesic. Franz PM; Anliker SL; Callaghan JT; DeSante KA; Dhahir PH; Nelson RL; Rubin A Drug Metab Dispos; 1990; 18(6):968-73. PubMed ID: 1981546 [TBL] [Abstract][Full Text] [Related]
20. Disposition and metabolism of a novel antineoplastic agent, 4-tert-butyl-[3-(2-chloroethyl)ureido]benzene, in mice. Maurizis JC; Rapp M; Azim EM; Gaudreault RC; Veyre A; Madelmont JC Drug Metab Dispos; 1998 Feb; 26(2):146-51. PubMed ID: 9456301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]